Ivermectin plus diethylcarbamazine: an additive effect on early microfilarial clearance.
The effects of ivermectin, diethylcarbamazine (DEC), and the combination of both drugs on levels of microfilaremia (mf) were studied in 30 male Polynesian Wuchereria bancrofti carriers. Microfilarial densities were measured 30 min (H1/2), 1 hr (H1), and 2, 4, 8, 24, and 96 hr (H2, H4, H8, H24, and H96) after supervised single doses of ivermectin plus DEC (400 micrograms/kg plus 1 mg/kg, respectively, 400 micrograms/kg plus 3 mg/kg, respectively, and 400 micrograms/kg plus 6 mg/kg, respectively), DEC (6 mg/kg) alone, and ivermectin (400 micrograms/kg and 100 micrograms/kg, respectively) alone given to six groups of five patients each. The results showed that 1) DEC alone or combined with ivermectin induced a rapid clearance of mf after drug intake; at H1/2, the number of circulating microfilariae was reduced to 16%, 8%, 28%, and 31%, respectively, of pretreatment values in the groups receiving ivermectin plus DEC (400 micrograms/kg plus 1 mg/kg, 400 micrograms/kg plus 3 mg/kg, and 400 micrograms/kg plus 6 mg/kg) and DEC (6 mg/kg) alone; 2) ivermectin alone induced a rapid increase of mf densities during the first 2 hr, followed by a sharp decrease from H4 to H96; and 3) between H8 and H96, mf clearance was almost complete with the combination of ivermectin and DEC. A comparison among groups did not show any synergistic interaction between ivermectin and DEC on the clearance of microfilaria, with the effect of each drug being additive to each another.
Moulia-Pelat
J P
JP
Institut Territorial de Recherches Medicales Louis Malarde, Papeete, Tahiti, French Polynesia.
Nguyen
L N
LN
Glaziou
P
P
Chanteau
S
S
Ottesen
E A
EA
Cardines
R
R
Martin
P M
PM
Cartel
J L
JL
D000818:Animals; D002353:Carrier State / Q000188:drug therapy* / Q000469:parasitology; D004049:Diethylcarbamazine / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004605:Elephantiasis, Filarial / Q000188:drug therapy* / Q000469:parasitology; D006801:Humans; D007559:Ivermectin / Q000494:pharmacology / Q000627:therapeutic use*; D007700:Kinetics; D008297:Male; D008842:Microfilariae / Q000187:drug effects; D014958:Wuchereria bancrofti / Q000187:drug effects*
D007559:Ivermectin; D004049:Diethylcarbamazine